Related Experiment Videos
Sleep Disorder Phenotypes and the Risk of Incident Heart Failure: A meta-analysis with Mendelian randomization
Fang Yan1, Lihua Fan2, Yunhu Chen2
1Laboratory Medicine Department, Taicang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, 215400, China.
Objectives:
To quantify how specific sleep-disorder phenotypes are related to incident heart failure (HF) using a meta-analysis of cohort data and to probe causal relevance via 2-sample Mendelian randomization (MR).
Methods:
Fourteen cohorts comprised of participants without HF at baseline were pooled (49,501 exposed; 337,317 controls). A random effects meta-analysis produced pooled hazard ratios (HRs) with 95% confidence intervals (CIs). A bidirectional two-sample MR was used to evaluate the causal effects of sleep phenotypes on HF.
Results:
Overall, sleep disorders were linked to a higher incidence of HF (pooled HR 1.46; 95% CI 1.30-1.63; p<0.001). In terms of phenotype, obstructive sleep apnea (OSA) was significantly associated (pooled HR 1.39; 95% CI 1.18-1.64; p < 0.001), whereas insomnia was not independently associated with HF (pooled HR 1.11; 95% CI 0.75-1.62; p = 0.609). The MR analyses supported a causal effect of OSA on HF (inverse-variance weighted odds ratio 1.12; 95% CI 1.03-1.23; p = 0.007) and revealed no causal evidence for insomnia.
Conclusions:
Sleep disorders are associated with increased HF risk, which varies by phenotype. Convergent observational and genetic evidence implicates OSA in increased HF risk, whereas insomnia shows no independent or causal association. These findings prioritize OSA screening and targeted prevention in HF risk mitigation.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Heart Failure IV: Classification and Diagnostic Evaluation
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy